| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Debbie Wasserman Schultz FL25 | 1 | 2 | −$2.0K | Sold Oct 20, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Oct 20, 25 | Debbie Wasserman Schultz FL25 | Child | Sell | $2,000.00 | Oct 24, 25 (4d) | |
| Jul 16, 25 | Debbie Wasserman Schultz FL25 | Self | Sell | $1,001 - $15,000 | Jul 25, 25 (9d) | |
| Jun 27, 25 | Debbie Wasserman Schultz FL25 | Child | Buy | $1,001 - $15,000 | Jul 25, 25 (28d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Nighan Warren G JrOfficer | Sale at price 14.72 per share. | 23.4K | $344.01K |
| Jul 21, 2026 | Clemmer James CChief Executive Officer | — | 52.4K | — |
| Jul 21, 2026 | Nighan Warren G JrOfficer | — | 5.7K | — |
| Jul 21, 2026 | Trowbridge Stephen AChief Financial Officer | — | 16.3K | — |
| Jul 21, 2026 | Campbell Chad ThomasOfficer | — | 6.5K | — |
| Jul 21, 2026 | Piccinini LauraOfficer | — | 8K | — |
| Jul 14, 2026 | Nighan Warren G JrOfficer | Stock Award(Grant) at price 0.00 per share. | 18K | — |
| Jul 14, 2026 | Tarnoff Michael EDirector | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Trowbridge Stephen AChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 53.3K | — |
| Jul 14, 2026 | Campbell Chad ThomasOfficer | Stock Award(Grant) at price 0.00 per share. | 16.1K | — |
| Jul 14, 2026 | Licitra Karen A.Director | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Burgess LorindaDirector | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Piccinini LauraOfficer | Stock Award(Grant) at price 0.00 per share. | 19.9K | — |
| Jul 14, 2026 | Lawrence Weiss TOfficer | Stock Award(Grant) at price 0.00 per share. | 21.3K | — |
| Jul 14, 2026 | Johnson Wesley E JrDirector | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Auen Eileen O SheaDirector | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Reed Jan Stern J.D.Director | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Jul 14, 2026 | Donnelly Howard WDirector | Stock Award(Grant) at price 0.00 per share. | 11.9K | — |
| Oct 20, 2025 | Lawrence Weiss TOfficer | Purchase at price 11.81 per share. | 10K | $118.10K |
| Oct 12, 2025 | Trowbridge Stephen AChief Financial Officer | Purchase at price 11.16 per share. | 890 | $9.93K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.3 | 10.4 | -0.6 | -3.8 | 4.9 | 13.3 | 13.7 | 9.1 | -4.6 | -25.9 | −11.2% | ||
| 2025 | 24.6 | -18.6 | 1.1 | -1.1 | 9.8 | -2.7 | -10.7 | 15.8 | 8.9 | 7.7 | 3.1 | 3.5 | +40.2% |
| 2024 | -24.7 | -6.9 | 6.9 | -1.4 | 9.0 | -4.1 | 29.6 | -4.8 | 4.3 | -14.0 | 3.6 | 32.2 | +16.8% |
| 2023 | -5.4 | -4.9 | -16.5 | -19.5 | 13.7 | 10.3 | -16.7 | -7.6 | -9.0 | -15.2 | 5.3 | 20.1 | −43.1% |
| 2022 | -21.6 | 8.8 | -8.5 | -2.3 | -6.7 | -1.4 | 17.3 | -2.4 | -7.6 | -31.1 | -8.1 | 6.3 | −50.1% |
| 2021 | 22.2 | 11.8 | 11.7 | 3.8 | -4.9 | 17.3 | -1.8 | 6.3 | -8.3 | 10.3 | -10.0 | 7.1 | +79.9% |
| 2020 | -14.0 | -16.6 | -9.2 | 0.0 | -2.1 | -0.4 | -18.8 | 13.4 | 28.7 | -14.3 | 37.5 | 7.8 | −4.2% |
| 2019 | 4.8 | 6.2 | 2.0 | -10.1 | -8.5 | 4.8 | 3.5 | -9.9 | 0.3 | -16.9 | 0.5 | 4.2 | −20.5% |
| 2018 | 4.7 | -6.4 | 5.9 | 12.3 | 8.5 | 5.8 | -4.9 | 6.1 | -3.0 | -6.0 | 5.2 | -6.3 | +21.0% |
| 2017 | -4.6 | 1.6 | 6.1 | -10.5 | -2.8 | 7.5 | 0.2 | 4.8 | 0.4 | -0.7 | 1.2 | -3.2 | −1.4% |
| 2016 | -6.8 | -4.0 | 13.1 | -0.3 | -2.0 | 19.7 | 15.4 | -0.3 | 6.0 | -9.1 | 2.3 | 3.5 | +39.0% |
| 2015 | 1.3 | -3.4 | -4.4 | -6.2 | -3.8 | 2.2 | -5.5 | -4.8 | -10.6 | -4.6 | -5.4 | 2.0 | −36.1% |
| 2014 | -7.3 | -3.2 | 2.3 | -14.7 | 6.6 | 14.0 | -10.6 | -3.4 | -2.8 | 23.9 | 2.9 | 8.6 | +10.8% |
| 2013 | 11.0 | 1.6 | -7.7 | -11.4 | 7.4 | 3.7 | 5.9 | -8.8 | 21.1 | 19.1 | -1.7 | 11.1 | +56.1% |
| 2012 | -12.5 | 0.5 | -5.9 | 1.1 | -2.7 | -0.2 | -8.3 | 3.9 | 6.6 | -12.0 | -1.8 | 4.3 | −25.8% |
| 2011 | 5.4 | 3.8 | -10.1 | 7.8 | -3.7 | -9.4 | -2.8 | 4.1 | -8.7 | 17.3 | -1.9 | -2.1 | −3.6% |
| 2010 | 0.0 | 1.3 | -3.9 | 2.3 | -7.6 | -0.1 | 4.5 | -1.2 | 0.1 | -6.7 | -1.8 | 10.0 | −4.2% |
| 2009 | -0.7 | -12.7 | -5.3 | 12.7 | -2.9 | 7.9 | -6.0 | 3.8 | 6.4 | 9.6 | 3.0 | 3.2 | +17.2% |
| 2008 | 6.5 | -18.2 | -30.3 | 27.9 | 4.8 | -12.1 | 16.6 | 3.5 | -3.8 | -20.3 | -5.3 | 14.8 | −28.1% |
| 2007 | 22.3 | -8.7 | -29.6 | -1.5 | -4.7 | 13.6 | 4.2 | 3.7 | -3.1 | 6.1 | -3.0 | -1.9 | −11.4% |
Buy / hold / sell counts
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.